Sivaiah et al. created pyrimidine products as anticancer (against MCF-7, HepG2, and A549 cancer cells) agents using erlotinib as a reference medication; they are powerful dual inhibitors of HDAC and EGFR [38]. Here, EGFR is linked to cancer.